CollabRx Announces Closing of Public Offering of Common Stock
25 juin 2014 16h13 HE
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) today announced the closing of its previously announced underwritten public offering of 913,500...
CollabRx Announces Pricing of Public Offering of Common Stock
19 juin 2014 18h14 HE
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) today announced the pricing of an underwritten public offering of 913,500 shares of its common stock,...
CollabRx Announces Successful Launch of CancerRx(TM) Mobile Oncology App
16 juin 2014 09h11 HE
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 16, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) today announced the successful launch of CancerRx™ - an IOS application designed to help...
CollabRx and Collaborators From The University of Chicago and the University of Wisconsin To Present New Clinical Data at the 2014 ASCO Annual Meeting
21 mai 2014 09h04 HE
|
CollabRx, Inc.
SAN FRANCISCO, May 21, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a data analytics company and leading provider of expert systems that inform therapeutic decision-making in...
CollabRx Appoints Clifford Baron as Chief Operating Officer
05 mars 2014 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, March 5, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of Clifford Baron, PhD as Vice President and Chief Operating Officer. Mr. Baron's most...
CollabRx Reports Third Quarter Fiscal Year 2014 Financial Results
11 févr. 2014 16h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 11, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the third quarter of fiscal year 2014, which ended December 31,...
CollabRx, Inc. Schedules Third Quarter Fiscal Year 2014 Financial Conference Call and Business Update
31 janv. 2014 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Jan. 31, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February...
CollabRx and CellNetix Partner to Advance Molecular Testing in Oncology
27 janv. 2014 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Jan. 27, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and CellNetix Pathology...
CollabRx to Present at the Sixth Annual Personalized Medicine World Conference
21 janv. 2014 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Jan. 21, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Gavin J....
CollabRx Launches New Web App for Cynvenio's ClearID Breast Cancer Patients
15 janv. 2014 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Jan. 15, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a leading data analytics company, today announced that its newest Therapy Finder for breast cancer patients will be made...